1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow satralizumab: new trials by email Literature Review of satralizumab trials Research Report on satralizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD) Satralizumab - Duchenne Muscular Dystrophy | Phase 2 | Active not recruiting | Hoffmann-La Roche | 30 | 2025-04-04 | 2026-09-04 |
| Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial) Satralizumab (Genetical Recombination) - Pulmonary Arterial Hypertension | Phase 2 | Completed | International University of Health and Welfare | 20 | 2022-07-12 | 2026-07-15 |
Fractures, Bone (1) · Inflammation (1) · Muscular Dystrophy, Duchenne (1) · Pulmonary Arterial Hypertension (1)
Hoffmann-La Roche (1) · International University of Health and Welfare (1)
Denmark (1) · Italy (1) · Japan (1) · Poland (1) · Spain (1) · Ukraine (1) · United States (1)
Yuichi Tamura (1)